Alex Madison | December 5th, 2016
Pharma’s Not-So-Lame Duck Session

Washington – and much of the politically aware public – is keenly focused on President-elect Trump™’s cabinet selections. But quietly, Congress has returned to work for its lame duck session and is poised to pass one of the most important bills of the year (with bipartisan support, no less!).
The 21st Century Cures Act, introduced by Republican Representative Fred Upton, is a wide-ranging piece of legislation that aims to improve public health through increased funding to the National Institutes of Health, speedier drug trials, support of opioid addition services, and greater health IT investments. It is widely regarded as a piece of legislation that will truly improve health outcomes.
It will also save pharmaceutical companies billions.
The bill is a huge victory for the industry, which is chiefly represented by The Pharmaceutical Researchers and Manufacturers of America, or PhRMA. Major pharma companies spend incredible sums of time and money adhering to government regulations concerning drug testing. The 21st Century Cures Act – if passed – will give the Food and Drug Administration discretion to reduce testing requirements on a case-by-case basis. The result will be a shorter to-market timeline for each drug and a substantially reduced development price tag.
Lost in the tempest of presidential politics has been the noteworthy K Street effort in support of the 21st Century Cures Act. According to The Center for Responsive Politics, almost 1,500 lobbyists representing 400 different organizations took part in shaping the bill. PhRMA alone spent nearly $25 million.
Too often, corporate lobbying (especially in health care) is met with kneejerk condemnation. But once the dust settles in Washington, the 21st Century Cures Act will get the attention it deserves. And in the opinion of this practitioner, we’ll find an excellent case study for how to execute a public affairs campaign that achieves mutually beneficial results and preserves industry/corporate reputation.
Alex Madison | December 5th, 2016
Pharma’s Not-So-Lame Duck Session

Washington – and much of the politically aware public – is keenly focused on President-elect Trump™’s cabinet selections. But quietly, Congress has returned to work for its lame duck session and is poised to pass one of the most important bills of the year (with bipartisan support, no less!).
The 21st Century Cures Act, introduced by Republican Representative Fred Upton, is a wide-ranging piece of legislation that aims to improve public health through increased funding to the National Institutes of Health, speedier drug trials, support of opioid addition services, and greater health IT investments. It is widely regarded as a piece of legislation that will truly improve health outcomes.
It will also save pharmaceutical companies billions.
The bill is a huge victory for the industry, which is chiefly represented by The Pharmaceutical Researchers and Manufacturers of America, or PhRMA. Major pharma companies spend incredible sums of time and money adhering to government regulations concerning drug testing. The 21st Century Cures Act – if passed – will give the Food and Drug Administration discretion to reduce testing requirements on a case-by-case basis. The result will be a shorter to-market timeline for each drug and a substantially reduced development price tag.
Lost in the tempest of presidential politics has been the noteworthy K Street effort in support of the 21st Century Cures Act. According to The Center for Responsive Politics, almost 1,500 lobbyists representing 400 different organizations took part in shaping the bill. PhRMA alone spent nearly $25 million.
Too often, corporate lobbying (especially in health care) is met with kneejerk condemnation. But once the dust settles in Washington, the 21st Century Cures Act will get the attention it deserves. And in the opinion of this practitioner, we’ll find an excellent case study for how to execute a public affairs campaign that achieves mutually beneficial results and preserves industry/corporate reputation.
- Brand
- The Fifth Estate: A Business Guide for Surviving “The Troubles”
- Here We Come
- Corporate Revolt Over Campaign Donations Shakes Political World
- What Happens Next?
- CSR & Sustainability
- Public Perception & the Biden Transition
- WATCH: Reputation Management with PRSA
- Over the River and Through The Woods
- Why Non-Profits are so Vulnerable to Crisis Risk
- The Threat to Free Markets
- What Happens When Nonprofits Get Caught In The Klieg Lights?
- You Took a PPP Loan. Now Get Ready to Talk About It.
- Communications
- The Fifth Estate: A Business Guide for Surviving “The Troubles”
- Here We Come
- The Ministry of Common Sense
- Why Should I Apologize? Lawyers vs. Communicators
- What Happens Next?
- CSR & Sustainability
- A Conversation with Abbe Lowell
- A New Year’s Resolution
- Public Perception & the Biden Transition
- WATCH: Reputation Management with PRSA
- Leveraging Legal Expertise in Communications
- Over the River and Through The Woods
- Company News
- Here We Come
- Recent Awards & Recognition
- Won’t You Be My Neighbor?
- What’s a Director to Do?
- LEVICK Announces Partnership with BCG
- A New Look
- Albert Krieger, 1923-2020
- LEVICK Announces Partnership with Jipyong
- Speaking to In-House Counsel
- Childhood Lessons
- LEVICK Announces New Webinar Series with Turbine Labs
- LEVICK Launches New Website
- Crisis
- The Fifth Estate: A Business Guide for Surviving “The Troubles”
- What to expect as the clock approaches midnight
- How to Stop the Madness
- Corporate Revolt Over Campaign Donations Shakes Political World
- A Remembrance of Tommy Raskin
- No ‘justice’ in rep’s vote
- A Call for Orderly & Peaceful Transition of Power
- Recovering from the Greatest Sacrifice
- The Cost of Government Regulation and the Threat to Free Enterprise
- What Happens Next?
- A Conversation with Abbe Lowell
- Covid-19: The Pandemic that Never Should Have Happened
- Finance
- Here We Come
- The Threat to Free Markets
- Advisory & Insurance Services
- WATCH: Revolutionizing Litigation Finance
- Litigation Finance: Revolutionizing Litigation
- Consumer-Focused Solutions for Financial Health
- Event: Consumer-Focused Solutions for Financial Health
- Sports: Power and Money in a New Age of Social Justice
- The Balancing Act: The Role of Whistleblowers in American Commerce and Government
- The Evolving and More Powerful FARA
- FCPA & Compliance in a Time of Uncertainty
- Shareholders vs. Stakeholders: Is the Paradigm Shifting?
- Guest Column
- Guest Blog: The Mainstream Media Gets an A for Intellectual Arrogance, an F for Journalism
- Buckle up Directors: Cybersecurity Risk and Bankruptcy Risk Are Not Mutually Exclusive
- Buckle up Directors: Cybersecurity Risk and Bankruptcy Risk Are Not Mutually Exclusive
- South Africa: The Slow Decline of the ANC
- Why CSR Fails and How to Fix It
- What to Expect Following the European Elections?
- Buhari Inaugurated. What Now for Nigeria?
- Marketing- It’s Up To You…
- Crisis Management lessons from the air-crash investigation model
- The Future of War
- Health
- Food Issues & the Biden Administration
- Covid-19: The Pandemic that Never Should Have Happened
- Pharma’s Post-Pandemic Policy Outlook
- Keeping Hope Alive
- Real Herd Immunity
- The Fiction of College Sports Amateurism
- Mac Summit: Crisis Communications in a Post-Covid, Post-Election World
- Travel Industry Communications in the Age of Covid-19
- Track of Time
- Is C-19 Taking Women Lawyers’ Careers Back to the 1950s?
- Post-Pandemic PR Strategy
- Bankruptcy: A Culture of Transparency
- In Memoriam
- Snider’s Super Foods: Locally World Famous
- Speak Truth With Love, Not Anger
- In Memoriam: Stephen Susman
- Letter to the Movement
- John Lewis’ Life Bridged the Best of America
- Albert Krieger, 1923-2020
- In Memoriam of Marcia Horowitz
- Jim Lehrer Passes Away
- Martin Luther King, Jr.
- Harold Burson Passes Away
- Interviews
- CommPRO: Ruth Bader Ginsberg’s Life & Legacy
- Richard Levick on “My Wakeup Call”
- Primerus Webinar: Into the Wind
- The Future of Baseball Post-Pandemic
- Webinar: The End of Brand Neutrality
- Thought Leadership & Organic Growth
- Man & Superman
- LEVICK Announces New Webinar Series with Turbine Labs
- Navigating Coronavirus Challenges in the Insurance Industry
- VIDEO: How to Anticipate & Avoid a Crisis
- What’s Next? with Julie Chase
- What’s Next?: California Electoral Behavior
- Law Firms
- Why Should I Apologize? Lawyers vs. Communicators
- You Took a PPP Loan. Now Get Ready to Talk About It.
- Beyond Black Swan: Positioning the law firm for the new normal
- A Salute to Personal Courage and the Rule of Law
- Cyber Risk Institute Expands Its Profile
- When a client becomes a law firm’s PR nightmare
- The General Counsel’s Dilemma
- A First Look at the Google Antitrust Suit
- The Latest Top Class Actions
- Trust on Trial: How Communicators Succeed in a World No Longer Trusted
- The Latest Settlements, Class actions, Investigations & More
- Managing Legal & Communication Advice in a Crisis
- Litigation
- Why Should I Apologize? Lawyers vs. Communicators
- A Conversation with Abbe Lowell
- Leveraging Legal Expertise in Communications
- You Took a PPP Loan. Now Get Ready to Talk About It.
- Beyond Black Swan: Positioning the law firm for the new normal
- A Salute to Personal Courage and the Rule of Law
- Cyber Risk Institute Expands Its Profile
- When a client becomes a law firm’s PR nightmare
- The General Counsel’s Dilemma
- WATCH: Revolutionizing Litigation Finance
- Litigation Finance: Revolutionizing Litigation
- A First Look at the Google Antitrust Suit
- Our Work
- Recent Awards & Recognition
- The Cyber Bad Guys Are Getting Worse
- Crisis Communications & The Age of Cancel Culture
- Standing on the Shoulders of Giants
- Video: Conversations with American Legends
- Staying Ahead of the Crisis
- A New Era of Insurance Marketing
- Infographic: Judgment Free Zone
- Infographic: Barriers to Entry
- Infographic: History Meter
- Assistance for Law Firms Engaged in Pro Bono
- Webinar: The End of Brand Neutrality
- Public Affairs
- The Fifth Estate: A Business Guide for Surviving “The Troubles”
- What to expect as the clock approaches midnight
- How to Stop the Madness
- Corporate Revolt Over Campaign Donations Shakes Political World
- No ‘justice’ in rep’s vote
- A Call for Orderly & Peaceful Transition of Power
- Recovering from the Greatest Sacrifice
- Food Issues & the Biden Administration
- The Cost of Government Regulation and the Threat to Free Enterprise
- What Happens Next?
- CSR & Sustainability
- A Conversation with Abbe Lowell
- Risk
- Ingredients of Decency
- ESG Performance and Credit Markets
- The Coronavirus Saga is Just Beginning
- No. 1 Risk of the Decade
- The Risk Evolution of Corporate Risk
- Extend Risk Management Reach
- Collective Action
- Risk Identifying Software
- The New Risk of Doing Nothing
- Political Unrest In Hong Kong
- High-Profile Kidnaps in African National Parks
- Cyber Resilience
- Social
- The Ministry of Common Sense
- How to Stop the Madness
- A Remembrance of Tommy Raskin
- No ‘justice’ in rep’s vote
- A Call for Orderly & Peaceful Transition of Power
- Recovering from the Greatest Sacrifice
- CSR & Sustainability
- A New Year’s Resolution
- Dropping the Mic
- Won’t You Be My Neighbor?
- Crisis, Covid, DEI & the Election
- MLK’s Memphis Address
- Technology
- Constella Intelligence Announces Hunter for Improved Investigation Capability
- Cyber Risk Institute Expands Its Profile
- Digital Politics: The Future of Voting Technology
- Ethics in Electronics
- The Cyber Bad Guys Are Getting Worse
- A First Look at the Google Antitrust Suit
- The Pause
- Cybersecurity Incidents of the Summer
- The Changing Digital Economy and Cyber Risks
- The Future of U.S. Manufacturing
- Tech CEO Summer Superbowl hearing
- Technology & Privacy Alert
- This Week
- A Remembrance of Tommy Raskin
- A New Year’s Resolution
- Over the River and Through The Woods
- Dropping the Mic
- Won’t You Be My Neighbor?
- The Cyber Bad Guys Are Getting Worse
- What We Hear
- Track of Time
- Video: Conversations with American Legends
- Conversations with American Legends
- A New Era of Insurance Marketing
- American Legend